Temsirolimus injection
Products billed under this code include Temsirolimus.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Temsirolimus.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Temsirolimus | Pfizer Inc | 00008-1179-01 | 25 | $692.675 |
| Temsirolimus | Accord Healthcare Inc | 16729-0223-61 | 25 | $692.675 |
| Temsirolimus | FreseniUS Kabi USA, LLC | 65219-0200-05 | 25 | $692.675 |
| Temsirolimus | Almaject, Inc. | 72611-0785-02 | 25 | $692.675 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $27.707 | −$4.974 | 1 MG | Temsirolimus injection | v1, posted September 17, 2026 |
| 3Q26 | $32.681 | +$2.603 | 1 MG | Temsirolimus injection | v1, posted September 15, 2026 |
| 2Q26 | $30.078 | +$9.762 | 1 MG | Temsirolimus injection | v1, posted September 15, 2026 |
| 1Q26 | $20.316 | −$6.396 | 1 MG | Temsirolimus injection | v1, posted September 15, 2026 |
| 4Q25 | $26.712 | −$5.574 | 1 MG | Temsirolimus injection | v1, posted September 8, 2026 |
| 3Q25 | $32.286 | +$1.969 | 1 MG | Temsirolimus injection | v1, posted March 10, 2026 |
| 2Q25 | $30.317 | +$0.799 | 1 MG | Temsirolimus injection | v1, posted March 10, 2026 |
| 1Q25 | $29.518 | −$2.692 | 1 MG | Temsirolimus injection | v1, posted December 19, 2025 |
| 4Q24 | $32.21 | +$1.46 | 1 MG | Temsirolimus injection | v1, posted June 11, 2025 |
| 3Q24 | $30.75 | +$1.887 | 1 MG | Temsirolimus injection | v1, posted June 11, 2025 |
| 2Q24 | $28.863 | −$2.13 | 1 MG | Temsirolimus injection | v1, posted March 11, 2025 |
| 1Q24 | $30.993 | +$1.314 | 1 MG | Temsirolimus injection | v1, posted December 19, 2024 |
| 4Q23 | $29.679 | −$3.891 | 1 MG | Temsirolimus injection | v1, posted October 10, 2024 |
| 3Q23 | $33.57 | +$1.402 | 1 MG | Temsirolimus injection | v1, posted June 5, 2024 |
| 2Q23 | $32.168 | −$3.032 | 1 MG | Temsirolimus injection | v1, posted February 23, 2024 |
| 1Q23 | $35.20 | +$3.32 | 1 MG | Temsirolimus injection | v1, posted December 6, 2023 |
| 4Q22 | $31.88 | −$1.03 | 1 MG | Temsirolimus injection | v1, posted June 22, 2023 |
| 3Q22 | $32.91 | −$2.438 | 1 MG | Temsirolimus injection | v1, posted June 9, 2023 |
| 2Q22 | $35.348 | +$0.60 | 1 MG | Temsirolimus injection | v1, posted December 14, 2022 |
| 1Q22 | $34.748 | −$3.499 | 1 MG | Temsirolimus injection | v1, posted June 8, 2022 |
| 4Q21 | $38.247 | +$0.613 | 1 MG | Temsirolimus injection | v1, posted June 2, 2022 |
| 3Q21 | $37.634 | −$2.76 | 1 MG | Temsirolimus injection | v1, posted June 2, 2022 |
| 2Q21 | $40.394 | −$2.464 | 1 MG | Temsirolimus injection | v1, posted March 1, 2022 |
| 1Q21 | $42.858 | – | 1 MG | Temsirolimus injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.